ATHE

Q: What is the price of Alterity Therapeutics (ATHE) today?

The price of Alterity Therapeutics (ATHE) today is $ 3.56, with return of 14.69% compared to the last year. The price of Alterity Therapeutics (ATHE) started the year trading around $ 3.08 and today it is at $ 3.56. Follow the real-time price chart, the historical price of Alterity Therapeutics (ATHE) and international markets.

Q: When does Alterity Therapeutics (ATHE) pay dividends?

Alterity Therapeutics (ATHE) did not distribute dividends in the last year.

Q: Is Alterity Therapeutics (ATHE) worth it?

Currently, Alterity Therapeutics (ATHE) is priced at $ 3.56, with a P/E of 0.00%, representing a deviation of -31,594,089% from its historical average P/E. In the last year, the stock showed a variation of 14.69 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 14.69%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Alterity Therapeutics (ATHE) stock?

Investing in stocks of Alterity Therapeutics (ATHE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Alterity Therapeutics (ATHE) yield today?

The yield of Alterity Therapeutics (ATHE) was 4.57% in the last month, 14.69% in the last year and -75.48% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Alterity Therapeutics (ATHE) today, the total investment would be $ 355.53, based on the current price of $ 3.56.If past performance were to repeat, the return on your investment would be:In 1 year: $ 407.76In 5 years: $ 87.18In 10 years: $ 44.01It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Alterity Therapeutics Limited

Price

$ 3.56

return (12m)

14.69%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ATHE price

ATHE

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ATHE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.57%

3 months

12.51%

1 year

14.69%

2 years

94.28%

5 years

-75.48%

10 years

-87.62%

Fundamentals ATHE

review the fundamentals of Alterity Therapeutics shares

P/E

0.00

Sector: -3.75 Industry: -3.75

P/S (PSR)

Sector: -4.18 Industry: -4.18

P/BV

0.00

Sector: 1.79 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.00%

Sector: -62.10% Industry: -62.10%

ROE

0.00%

Sector: -62.98% Industry: -62.98%

ROIC

0.00%

Sector: -1,220.49% Industry: -1,220.49%

NET MARGIN

0.00%

Sector: -39.10% Industry: -39.10%

GROSS MARGIN

0.00%

Sector: 38.12% Industry: 38.12%

OPERATING MARGIN

0.00%

Sector: -39.31% Industry: -39.31%

EV/EBITDA

Sector: -3.57 Industry: -3.57

EV/EBIT

Sector: -3.78 Industry: -3.78

PRICE-TO-ASSETS

Sector: 1.30 Industry: 1.30

BVPS

Sector: 1.88 Industry: 1.88

EPS

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ATHE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.61	7.31	33.81%	2.16%	$ 579.24 B	28.46%
PFE	19.79	1.65	8.35%	6.36%	$ 153.75 B	12.42%
ABBV	87.56	0.00	0.00%	3.18%	$ 370.01 B	6.91%
NVO	10.22	5.26	51.50%	4.68%	$ 160.05 B	33.05%
MRK	16.27	0.00	0.00%	2.74%	$ 296.92 B	28.08%
AZN	28.58	6.00	20.99%	1.70%	$ 292.24 B	17.41%
GILD	19.48	7.33	37.62%	2.39%	$ 165.80 B	28.90%
BMY	16.90	-3.50	-20.72%	4.25%	$ 119.19 B	14.64%
ZTS	18.57	14.90	80.25%	1.79%	$ 49.65 B	28.23%
REGN	16.87	2.43	14.41%	0.49%	$ 75.98 B	31.41%
HALO	22.95	148.99	649.21%	0.00%	$ 7.27 B	22.69%
AMGN	24.38	21.71	89.06%	2.77%	$ 187.99 B	20.98%
MCK	24.38	-1,068.68	-4,383.84%	0.36%	$ 105.80 B	1.09%
VRTX	27.83	5.89	21.18%	0.00%	$ 110.00 B	32.94%
CAH	29.33	-18.06	-61.56%	0.99%	$ 48.75 B	0.68%
ADMA	14.98	4.61	30.78%	0.00%	$ 2.20 B	28.80%
BIIB	20.90	1.48	7.08%	0.00%	$ 27.02 B	13.07%
HRMY	9.53	1.74	18.24%	0.00%	$ 1.51 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ATHE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Alterity Therapeutics

Alterity Therapeutics Limited

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2002

Time since IPO - 24 years

11

Employees

The Company Alterity Therapeutics Limited (United States), is listed on Nasdaq with a market value of $ 7.71 Billions, having an equity of $ -.

With a total of 11 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -.

As for its main indicators, the Company has a P/E ratio of 0.00, a P/BV ratio of 0.00 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ATHE.

Market cap

$ 7.71 Billions

Net worth

$ -

US$ -

Assets

$ -

US$ -

Total Shares Outstanding

2.44 Billions

2,439,897,000

Average Daily Trading Volume

$ 11.65 Thousand

US$ 11,646.08

Sector

Health Care

Industry

Biotechnology

ATHE

ATHE revenue and profits

Financial Results ATHE

DRAG THE FRAME TO SEE MORE DATA

ATHE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 23,83% (12M)

P/E

24.38

0.36%

ROE

-4,383.84%

P/BV

-1,068.68

CAH - Cardinal Health

$ 214.05 58,49% (12M)

P/E

29.33

0.99%

ROE

-61.56%

P/BV

-18.06

JNJ - Johnson & Johnson

$ 243.04 56,31% (12M)

P/E

21.61

2.16%

ROE

33.81%

P/BV

7.31

PFE - Pfizer

$ 28.32 25,05% (12M)

P/E

19.79

6.36%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 208.84 7,85% (12M)

P/E

87.56

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 46,25% (12M)

P/E

16.27

2.74%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 51,28% (12M)

P/E

28.58

1.70%

ROE

20.99%

P/BV

6.00

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 23,83% (12 M)

P/L

24.38

0.36%

ROE

-4,383.84%

P/VP

-1,068.68

CAH - Cardinal Health

$ 214.05 58,49% (12 M)

P/L

29.33

0.99%

ROE

-61.56%

P/VP

-18.06

JNJ - Johnson & Johnson

$ 243.04 56,31% (12 M)

P/L

21.61

2.16%

ROE

33.81%

P/VP

7.31

PFE - Pfizer

$ 28.32 25,05% (12 M)

P/L

19.79

6.36%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 208.84 7,85% (12 M)

P/L

87.56

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 46,25% (12 M)

P/L

16.27

2.74%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 51,28% (12 M)

P/L

28.58

1.70%

ROE

20.99%

P/VP

6.00

Frequently Asked Questions

What is the price of Alterity Therapeutics (ATHE) today?

The price of Alterity Therapeutics (ATHE) today is $ 3.56, with return of 14.69% compared to the last year. The price of Alterity Therapeutics (ATHE) started the year trading around $ 3.08 and today it is at $ 3.56. Follow the real-time price chart, the historical price of Alterity Therapeutics (ATHE) and international markets.

When does Alterity Therapeutics (ATHE) pay dividends?

Alterity Therapeutics (ATHE) did not distribute dividends in the last year.

Is Alterity Therapeutics (ATHE) worth it?

Currently, Alterity Therapeutics (ATHE) is priced at $ 3.56, with a P/E of 0.00%, representing a deviation of -31,594,089% from its historical average P/E. In the last year, the stock showed a variation of 14.69 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 14.69%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Alterity Therapeutics (ATHE) stock?

Investing in stocks of Alterity Therapeutics (ATHE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Alterity Therapeutics (ATHE) yield today?

The yield of Alterity Therapeutics (ATHE) was 4.57% in the last month, 14.69% in the last year and -75.48% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Alterity Therapeutics (ATHE) today, the total investment would be $ 355.53, based on the current price of $ 3.56.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 407.76
In 5 years: $ 87.18
In 10 years: $ 44.01

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ATHE

Alterity Therapeutics Limited

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ATHE

review the fundamentals of Alterity Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Alterity Therapeutics

Alterity Therapeutics Limited

United States

29 years

2002

11

PROFIT X PRICE ATHE

Financial Results ATHE

ATHE cash flow

Asset, Revenue and Profit Growth - ATHE

ATHE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions